Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avanti: GnRH Agonist vs Antagonist for PGD
NCT01888744Phase 4Completed
- Sponsor
- UZ Brussel
- Start
- Sep 2010
- Primary completion
- Jun 2013
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ganirelix, cetrorelix, triptorelin and buserelin in female infertility (2 arms), sponsored by UZ Brussel. Primary endpoint: Number of day 3 embryos for biopsy available up to 6 weeks. Started Sep 2010; status: completed.
02
Drugs
ganirelixcetrorelixtriptorelinbuserelin
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT01888744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01888744.